05/07/2019

Newsletters of Interest

A Few Articles You Won’t Want to Miss:

• Changes to our National Precertification List (NPL)
• Changes to commercial drug lists begin on July 1, 2019

And Much More….MARCH OfficeLink Updates Qtly Issue Available HERE

A Few Articles You Won’t Want to Miss:

• Here’s how to confirm the networks you participate in
• Medical record guidelines policies require providers to maintain member records
• Inflectra to be the preferred infliximab product for adult BCN Commercial members
• AIM Specialty Health to manage medical oncology medications for BCN starting August 1
• We’ve made additional changes to the peer-to-peer review process

And Much More…MAY/JUNE Bi-Monthly Issue Available HERE

Current Issue Available HERE

Current Issue Available HERE 
(Once on the site, scroll to the bottom and choose NEWS on the left side)

A Few Articles You Won’t Want to Miss:

• Humana Updates Preauthorization and Notification Lists for 2019
• Changes Announced for 2019 Humana Formularies
• New and Revised Pharmacy and Medical Coverage Policies Available

And Much More…Latest Issue Available HERE 
(Latest update February 2019)

 A Few Articles You Won’t Want to Miss:

• Front & Center
  • Smart Edits Announces Informational Release Edits to Alert You Ahead of Time
  • UnitedHealthcare Preferred Lab Network Launches July 1, 2019
  • Out-of-Network Lab Approval Required Aug. 1, 2019
  • Updates to Requirements for Specialty Medical Injectable Drugs for UnitedHealthcare Commercial and Community Plan
  • Pharmacy Update: Notice of Changes to Prior Authorization Requirements and Coverage Criteria for UnitedHealthcare Commercial and Oxford
  • Global Shortage of Bacillus Calmette -Guérin (BCG) for Bladder Cancer

• UnitedHealthcare Commercial
  • Risk Adjustment Data Validation (RADV)Audit Program
  • UnitedHealthcare Outpatient Injectable Cancer Therapy Prior Authorization Requirement

And Much More…MAY Monthly Issue Available HERE

Oncology Related Articles You Won’t Want to Miss:

Medical Benefit Drug Policy Updates

Revised:

• Complement Inhibitors (Soliris® & Ultomiris™) – Effective May 1, 2019
• Maximum Dosage – Effective May 1, 2019

Utilization Review Guideline (URG) Updates

Updated:

• Immune Globulin – Site of Care – Effective May 1, 2019

MAY Monthly Issue Available HERE